title: Deficiency in the 15-kDa selenoprotein inhibits tumorigenicity and metastasis of colon cancer cells.
abstract: Selenium has cancer-preventive activity that is mediated, in part, through selenoproteins. The role of the 15-kDa selenoprotein (Sep15) in colon cancer was assessed by preparing and using mouse colon CT26 cells stably transfected with short hairpin RNA constructs targeting Sep15. Metabolic (75)Se labeling and Northern and Western blot analyses revealed that >90% of Sep15 was downregulated. Growth of the resulting Sep15-deficient CT26 cells was reduced (P < 0.01), and cells formed significantly (P < 0.001) fewer colonies in soft agar compared with control CT26 cells. Whereas most (14 of 15) BALB/c mice injected with control cells developed tumors, few (3 of 30) mice injected with Sep15-deficient cells developed tumors (P < 0.0001). The ability to form pulmonary metastases had similar results. Mice injected with the plasmid-transfected control cells had >250 lung metastases per mouse; however, mice injected with cells with downregulation of Sep15 only had 7.8 +/- 5.4 metastases. To investigate molecular targets affected by Sep15 status, gene expression patterns between control and knockdown CT26 cells were compared. Ingenuity Pathways Analysis was used to analyze the 1,045 genes that were significantly (P < 0.001) affected by Sep15 deficiency. The highest-scored biological functions were cancer and cellular growth and proliferation. Consistent with these observations, subsequent analyses revealed a G(2)-M cell cycle arrest in cells with targeted downregulation of Sep15. In contrast to CT26 cells, Sep15-targeted downregulation in Lewis lung carcinoma (LLC1) cells did not affect anchorage-dependent or anchorage-independent cell growth. These data suggest tissue specificity in the cancer-protective effects of Sep15 downregulation, which are mediated, at least in part, by influencing the cell cycle.
authors.affiliation: Nutritional Science Research Group, Molecular Biology of Selenium Section, Laboratory of Cancer Prevention, National Cancer Institute, Rockville, MD 20892-7328, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Irons
authors.forename: Petra A
authors.initials: PA
authors.lastname: Tsuji
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Carlson
authors.forename: Ping
authors.initials: P
authors.lastname: Ouyang
authors.forename: Min-Hyuk
authors.initials: MH
authors.lastname: Yoo
authors.forename: Xue-Ming
authors.initials: XM
authors.lastname: Xu
authors.forename: Dolph L
authors.initials: DL
authors.lastname: Hatfield
authors.forename: Vadim N
authors.initials: VN
authors.lastname: Gladyshev
authors.forename: Cindy D
authors.initials: CD
authors.lastname: Davis
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D015153:Blotting, Western; D018827:Carcinoma, Lewis Lung; D002453:Cell Cycle / Q000235:genetics; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009361:Neoplasm Invasiveness / Q000235:genetics* / Q000473:pathology; D020411:Oligonucleotide Array Sequence Analysis; D034741:RNA, Small Interfering; D020133:Reverse Transcriptase Polymerase Chain Reaction; D051140:Selenoproteins / Q000172:deficiency* / Q000235:genetics; D014162:Transfection
chemical_list: D034741:RNA, Small Interfering; C495239:Selenof protein, mouse; D051140:Selenoproteins
references.citation: JAMA. 1996 Dec 25;276(24):1957-63
references.pmid: 8971064
references.citation: Mol Cell Biol. 2003 Mar;23(6):2109-22
references.pmid: 12612082
references.citation: Dis Colon Rectum. 1996 Jun;39(6):628-31
references.pmid: 8646947
references.citation: Nat Protoc. 2009;4(1):44-57
references.pmid: 19131956
references.citation: J Nutr. 2003 Sep;133(9):2907-14
references.pmid: 12949386
references.citation: Anal Biochem. 1997 Nov 1;253(1):123-5
references.pmid: 9356150
references.citation: J Biol Chem. 2006 May 12;281(19):13005-13008
references.pmid: 16565519
references.citation: Science. 2003 May 30;300(5624):1439-43
references.pmid: 12775843
references.citation: J Nutr. 2006 May;136(5):1311-7
references.pmid: 16614422
references.citation: J Biol Chem. 2005 Dec 16;280(50):41568-75
references.pmid: 16230358
references.citation: PLoS One. 2007 Oct 31;2(10):e1112
references.pmid: 17971875
references.citation: Oncogene. 2007 Jul 19;26(33):4825-32
references.pmid: 17297447
references.citation: Eur J Biochem. 2000 Oct;267(20):6102-9
references.pmid: 11012661
references.citation: J Lab Clin Med. 1967 Jul;70(1):158-69
references.pmid: 6066618
references.citation: J Nutr. 2003 Sep;133(9):2721-7
references.pmid: 12949356
references.citation: Methods Enzymol. 1995;252:199-208
references.pmid: 7476354
references.citation: J Biol Chem. 2005 Feb 18;280(7):5542-8
references.pmid: 15611090
references.citation: Genome Biol. 2003;4(5):P3
references.pmid: 12734009
references.citation: Oncogene. 2004 Jun 24;23(29):5032-40
references.pmid: 15107826
references.citation: Oncogene. 2009 Aug 20;28(33):2959-68
references.pmid: 19543318
references.citation: Eur J Nutr. 2008 Feb;47(1):47-54
references.pmid: 18239845
references.citation: IUBMB Life. 2007 Jan;59(1):1-5
references.pmid: 17365173
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: J Biol Chem. 2000 Nov 10;275(45):35540-7
references.pmid: 10945981